-+ 0.00%
-+ 0.00%
-+ 0.00%

Korean Intellectual Property Office Granted Conduit Pharmaceuticals Composition Of Matter Patent For AZD1656

Benzinga·05/09/2025 12:31:39
Listen to the news

Conduit secures a composition of matter patent from the Korean Intellectual Property Office for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and strategic partnerships.